Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®.
Rabdano SO, Ruzanova EA, Pletyukhina IV, Saveliev NS, Kryshen KL, Katelnikova AE, Beltyukov PP, Fakhretdinova LN, Safi AS, Rudakov GO, Arakelov SA, Andreev IV, Kofiadi IA, Khaitov MR, Valenta R, Kryuchko DS, Berzin IA, Belozerova NS, Evtushenko AE, Truhin VP, Skvortsova VI.
Rabdano SO, et al. Among authors: katelnikova ae.
Vaccines (Basel). 2023 Apr 20;11(4):874. doi: 10.3390/vaccines11040874.
Vaccines (Basel). 2023.
PMID: 37112786
Free PMC article.